Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ) (XVIPY) Stock Competitors & Peer Comparison
See (XVIPY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| XVIPY | $6.54 | +0.00% | 206M | N/A | N/A | N/A |
| SEMHF | $40.32 | +0.80% | 44B | 17.85 | $2.20 | +3.03% |
| RSMDF | $17.93 | +1.19% | 26B | 17.24 | $1.04 | +1.14% |
| RYLPF | $26.65 | +2.50% | 25.4B | 22.98 | $1.16 | +3.73% |
| FUJIF | $20.45 | +0.00% | 24.6B | 14.40 | $1.42 | +2.23% |
| FUJIY | $9.96 | +0.50% | 24B | 14.00 | $0.71 | +3.06% |
| SMMNY | $19.95 | +1.94% | 22.3B | 17.97 | $1.11 | +2.98% |
| SONVF | $262.10 | +7.67% | 15.9B | 23.33 | $11.44 | +2.03% |
| SONVY | $51.92 | +3.36% | 15.3B | 22.49 | $2.29 | +2.09% |
| CLPBY | $6.46 | +2.70% | 14.6B | 43.17 | $0.15 | +5.57% |
Stock Comparison
XVIPY vs SEMHF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SEMHF has a market cap of 44B. Regarding current trading prices, XVIPY is priced at $6.54, while SEMHF trades at $40.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SEMHF's P/E ratio is 17.85. In terms of profitability, XVIPY's ROE is +0.01%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, XVIPY and SEMHF have similar daily volatility (0.00).Check SEMHF's competition here
XVIPY vs RSMDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RSMDF has a market cap of 26B. Regarding current trading prices, XVIPY is priced at $6.54, while RSMDF trades at $17.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RSMDF's P/E ratio is 17.24. In terms of profitability, XVIPY's ROE is +0.01%, compared to RSMDF's ROE of +0.24%. Regarding short-term risk, XVIPY is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check RSMDF's competition here
XVIPY vs RYLPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RYLPF has a market cap of 25.4B. Regarding current trading prices, XVIPY is priced at $6.54, while RYLPF trades at $26.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RYLPF's P/E ratio is 22.98. In terms of profitability, XVIPY's ROE is +0.01%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, XVIPY and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
XVIPY vs FUJIF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, FUJIF has a market cap of 24.6B. Regarding current trading prices, XVIPY is priced at $6.54, while FUJIF trades at $20.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas FUJIF's P/E ratio is 14.40. In terms of profitability, XVIPY's ROE is +0.01%, compared to FUJIF's ROE of +0.10%. Regarding short-term risk, XVIPY and FUJIF have similar daily volatility (0.00).Check FUJIF's competition here
XVIPY vs FUJIY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, FUJIY has a market cap of 24B. Regarding current trading prices, XVIPY is priced at $6.54, while FUJIY trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas FUJIY's P/E ratio is 14.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to FUJIY's ROE of +0.08%. Regarding short-term risk, XVIPY is less volatile compared to FUJIY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check FUJIY's competition here
XVIPY vs SMMNY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SMMNY has a market cap of 22.3B. Regarding current trading prices, XVIPY is priced at $6.54, while SMMNY trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SMMNY's P/E ratio is 17.97. In terms of profitability, XVIPY's ROE is +0.01%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, XVIPY is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check SMMNY's competition here
XVIPY vs SONVF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SONVF has a market cap of 15.9B. Regarding current trading prices, XVIPY is priced at $6.54, while SONVF trades at $262.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SONVF's P/E ratio is 23.33. In terms of profitability, XVIPY's ROE is +0.01%, compared to SONVF's ROE of +0.21%. Regarding short-term risk, XVIPY is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check SONVF's competition here
XVIPY vs SONVY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SONVY has a market cap of 15.3B. Regarding current trading prices, XVIPY is priced at $6.54, while SONVY trades at $51.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SONVY's P/E ratio is 22.49. In terms of profitability, XVIPY's ROE is +0.01%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, XVIPY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check SONVY's competition here
XVIPY vs CLPBY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CLPBY has a market cap of 14.6B. Regarding current trading prices, XVIPY is priced at $6.54, while CLPBY trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CLPBY's P/E ratio is 43.17. In terms of profitability, XVIPY's ROE is +0.01%, compared to CLPBY's ROE of +0.14%. Regarding short-term risk, XVIPY is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CLPBY's competition here
XVIPY vs CLPBF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CLPBF has a market cap of 12.8B. Regarding current trading prices, XVIPY is priced at $6.54, while CLPBF trades at $61.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CLPBF's P/E ratio is 42.67. In terms of profitability, XVIPY's ROE is +0.01%, compared to CLPBF's ROE of +0.14%. Regarding short-term risk, XVIPY is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CLPBF's competition here
XVIPY vs SNNUF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, XVIPY is priced at $6.54, while SNNUF trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SNNUF's P/E ratio is 20.71. In terms of profitability, XVIPY's ROE is +0.01%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, XVIPY is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check SNNUF's competition here
XVIPY vs OCPNF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, OCPNF has a market cap of 12.3B. Regarding current trading prices, XVIPY is priced at $6.54, while OCPNF trades at $11.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas OCPNF's P/E ratio is 28.67. In terms of profitability, XVIPY's ROE is +0.01%, compared to OCPNF's ROE of +0.09%. Regarding short-term risk, XVIPY and OCPNF have similar daily volatility (0.00).Check OCPNF's competition here
XVIPY vs WILYY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, WILYY has a market cap of 7.6B. Regarding current trading prices, XVIPY is priced at $6.54, while WILYY trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas WILYY's P/E ratio is 20.75. In terms of profitability, XVIPY's ROE is +0.01%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, XVIPY is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check WILYY's competition here
XVIPY vs WILLF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, XVIPY is priced at $6.54, while WILLF trades at $35.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas WILLF's P/E ratio is 20.14. In terms of profitability, XVIPY's ROE is +0.01%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, XVIPY and WILLF have similar daily volatility (0.00).Check WILLF's competition here
XVIPY vs GNGBY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, GNGBY has a market cap of 5.7B. Regarding current trading prices, XVIPY is priced at $6.54, while GNGBY trades at $20.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas GNGBY's P/E ratio is 22.62. In terms of profitability, XVIPY's ROE is +0.01%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, XVIPY is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check GNGBY's competition here
XVIPY vs GNGBF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, XVIPY is priced at $6.54, while GNGBF trades at $20.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas GNGBF's P/E ratio is 22.03. In terms of profitability, XVIPY's ROE is +0.01%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, XVIPY and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
XVIPY vs YPHDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, XVIPY is priced at $6.54, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas YPHDF's P/E ratio is 19.69. In terms of profitability, XVIPY's ROE is +0.01%, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, XVIPY is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check YPHDF's competition here
XVIPY vs CHEOY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CHEOY has a market cap of 4.5B. Regarding current trading prices, XVIPY is priced at $6.54, while CHEOY trades at $34.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CHEOY's P/E ratio is 18.25. In terms of profitability, XVIPY's ROE is +0.01%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, XVIPY is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CHEOY's competition here
XVIPY vs CHEOF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CHEOF has a market cap of 4.4B. Regarding current trading prices, XVIPY is priced at $6.54, while CHEOF trades at $67.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CHEOF's P/E ratio is 17.90. In terms of profitability, XVIPY's ROE is +0.01%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, XVIPY is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CHEOF's competition here
XVIPY vs NHNKY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, NHNKY has a market cap of 3.1B. Regarding current trading prices, XVIPY is priced at $6.54, while NHNKY trades at $9.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas NHNKY's P/E ratio is 16.83. In terms of profitability, XVIPY's ROE is +0.01%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, XVIPY is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check NHNKY's competition here
XVIPY vs AMFPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AMFPF has a market cap of 2.8B. Regarding current trading prices, XVIPY is priced at $6.54, while AMFPF trades at $12.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AMFPF's P/E ratio is 35.03. In terms of profitability, XVIPY's ROE is +0.01%, compared to AMFPF's ROE of +0.07%. Regarding short-term risk, XVIPY and AMFPF have similar daily volatility (0.00).Check AMFPF's competition here
XVIPY vs AMBBY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AMBBY has a market cap of 2.7B. Regarding current trading prices, XVIPY is priced at $6.54, while AMBBY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AMBBY's P/E ratio is 36.43. In terms of profitability, XVIPY's ROE is +0.01%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, XVIPY and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here
XVIPY vs AMBFF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AMBFF has a market cap of 2.6B. Regarding current trading prices, XVIPY is priced at $6.54, while AMBFF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AMBFF's P/E ratio is 35.36. In terms of profitability, XVIPY's ROE is +0.01%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, XVIPY and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here
XVIPY vs NHNKF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, XVIPY is priced at $6.54, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, XVIPY's ROE is +0.01%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, XVIPY is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check NHNKF's competition here
XVIPY vs MCRPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, XVIPY is priced at $6.54, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, XVIPY's ROE is +0.01%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, XVIPY and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
XVIPY vs GNNDY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, XVIPY is priced at $6.54, while GNNDY trades at $43.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas GNNDY's P/E ratio is 51.88. In terms of profitability, XVIPY's ROE is +0.01%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, XVIPY is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check GNNDY's competition here
XVIPY vs GGNDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, XVIPY is priced at $6.54, while GGNDF trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas GGNDF's P/E ratio is 52.14. In terms of profitability, XVIPY's ROE is +0.01%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, XVIPY is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check GGNDF's competition here
XVIPY vs DRWKF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, XVIPY is priced at $6.54, while DRWKF trades at $111.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DRWKF's P/E ratio is 11.79. In terms of profitability, XVIPY's ROE is +0.01%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, XVIPY is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check DRWKF's competition here
XVIPY vs OSSFF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, XVIPY is priced at $6.54, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, XVIPY's ROE is +0.01%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, XVIPY is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check OSSFF's competition here
XVIPY vs DWRKF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, XVIPY is priced at $6.54, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, XVIPY's ROE is +0.01%, compared to DWRKF's ROE of N/A. Regarding short-term risk, XVIPY and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
XVIPY vs BOEUF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BOEUF has a market cap of 1.7B. Regarding current trading prices, XVIPY is priced at $6.54, while BOEUF trades at $28.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BOEUF's P/E ratio is 90.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to BOEUF's ROE of +0.22%. Regarding short-term risk, XVIPY and BOEUF have similar daily volatility (0.00).Check BOEUF's competition here
XVIPY vs MEDGF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, XVIPY is priced at $6.54, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, XVIPY's ROE is +0.01%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, XVIPY and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
XVIPY vs OSSUY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, XVIPY is priced at $6.54, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, XVIPY's ROE is +0.01%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, XVIPY is less volatile compared to OSSUY. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check OSSUY's competition here
XVIPY vs DGWPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DGWPF has a market cap of 1.6B. Regarding current trading prices, XVIPY is priced at $6.54, while DGWPF trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DGWPF's P/E ratio is 8.70. In terms of profitability, XVIPY's ROE is +0.01%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, XVIPY is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check DGWPF's competition here
XVIPY vs VTRLY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, XVIPY is priced at $6.54, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas VTRLY's P/E ratio is -2.77. In terms of profitability, XVIPY's ROE is +0.01%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, XVIPY and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
XVIPY vs FDMDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, FDMDF has a market cap of 1.5B. Regarding current trading prices, XVIPY is priced at $6.54, while FDMDF trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas FDMDF's P/E ratio is -8.62. In terms of profitability, XVIPY's ROE is +0.01%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, XVIPY and FDMDF have similar daily volatility (0.00).Check FDMDF's competition here
XVIPY vs MDRSF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, XVIPY is priced at $6.54, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, XVIPY's ROE is +0.01%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, XVIPY and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here
XVIPY vs ELEAF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, XVIPY is priced at $6.54, while ELEAF trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ELEAF's P/E ratio is 21.83. In terms of profitability, XVIPY's ROE is +0.01%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, XVIPY is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ELEAF's competition here
XVIPY vs LFTSF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, XVIPY is priced at $6.54, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, XVIPY's ROE is +0.01%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, XVIPY and LFTSF have similar daily volatility (0.00).Check LFTSF's competition here
XVIPY vs XVIPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, XVIPF has a market cap of 925.8M. Regarding current trading prices, XVIPY is priced at $6.54, while XVIPF trades at $29.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas XVIPF's P/E ratio is 117.56. In terms of profitability, XVIPY's ROE is +0.01%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, XVIPY is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check XVIPF's competition here
XVIPY vs BRSYF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BRSYF has a market cap of 674.3M. Regarding current trading prices, XVIPY is priced at $6.54, while BRSYF trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BRSYF's P/E ratio is 76.55. In terms of profitability, XVIPY's ROE is +0.01%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, XVIPY is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check BRSYF's competition here
XVIPY vs CALZF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CALZF has a market cap of 529.4M. Regarding current trading prices, XVIPY is priced at $6.54, while CALZF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CALZF's P/E ratio is 76.62. In terms of profitability, XVIPY's ROE is +0.01%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, XVIPY is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CALZF's competition here
XVIPY vs IOBCF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, IOBCF has a market cap of 501.5M. Regarding current trading prices, XVIPY is priced at $6.54, while IOBCF trades at $17.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas IOBCF's P/E ratio is 34.90. In terms of profitability, XVIPY's ROE is +0.01%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, XVIPY and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
XVIPY vs AVMR Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, XVIPY is priced at $6.54, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AVMR's P/E ratio is -18.34. In terms of profitability, XVIPY's ROE is +0.01%, compared to AVMR's ROE of -0.23%. Regarding short-term risk, XVIPY and AVMR have similar daily volatility (0.00).Check AVMR's competition here
XVIPY vs DMTRF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, XVIPY is priced at $6.54, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, XVIPY is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check DMTRF's competition here
XVIPY vs CYBQY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CYBQY has a market cap of 365.6M. Regarding current trading prices, XVIPY is priced at $6.54, while CYBQY trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CYBQY's P/E ratio is -205.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to CYBQY's ROE of +0.01%. Regarding short-term risk, XVIPY and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
XVIPY vs HYBT Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, XVIPY is priced at $6.54, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas HYBT's P/E ratio is N/A. In terms of profitability, XVIPY's ROE is +0.01%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, XVIPY and HYBT have similar daily volatility (0.00).Check HYBT's competition here
XVIPY vs CSSPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CSSPF has a market cap of 336.4M. Regarding current trading prices, XVIPY is priced at $6.54, while CSSPF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CSSPF's P/E ratio is 39.98. In terms of profitability, XVIPY's ROE is +0.01%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, XVIPY is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CSSPF's competition here
XVIPY vs CLVSF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, XVIPY is priced at $6.54, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CLVSF's P/E ratio is 22.86. In terms of profitability, XVIPY's ROE is +0.01%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, XVIPY is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CLVSF's competition here
XVIPY vs EBRCZ Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, EBRCZ has a market cap of 277.4M. Regarding current trading prices, XVIPY is priced at $6.54, while EBRCZ trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas EBRCZ's P/E ratio is -1.69. In terms of profitability, XVIPY's ROE is +0.01%, compared to EBRCZ's ROE of -1.80%. Regarding short-term risk, XVIPY and EBRCZ have similar daily volatility (0.00).Check EBRCZ's competition here
XVIPY vs CYBQF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CYBQF has a market cap of 246.8M. Regarding current trading prices, XVIPY is priced at $6.54, while CYBQF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CYBQF's P/E ratio is -185.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to CYBQF's ROE of +0.00%. Regarding short-term risk, XVIPY and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
XVIPY vs HTLZF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, XVIPY is priced at $6.54, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, XVIPY's ROE is +0.01%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, XVIPY and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
XVIPY vs IMPZY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, XVIPY is priced at $6.54, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, XVIPY's ROE is +0.01%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, XVIPY and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
XVIPY vs VMTHF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, XVIPY is priced at $6.54, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, XVIPY's ROE is +0.01%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, XVIPY and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
XVIPY vs BCCOY Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BCCOY has a market cap of 183.5M. Regarding current trading prices, XVIPY is priced at $6.54, while BCCOY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BCCOY's P/E ratio is -1.16. In terms of profitability, XVIPY's ROE is +0.01%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, XVIPY and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here
XVIPY vs DTXMF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, XVIPY is priced at $6.54, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, XVIPY's ROE is +0.01%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, XVIPY is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check DTXMF's competition here
XVIPY vs CLLKF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CLLKF has a market cap of 157.5M. Regarding current trading prices, XVIPY is priced at $6.54, while CLLKF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CLLKF's P/E ratio is -1.03. In terms of profitability, XVIPY's ROE is +0.01%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, XVIPY is less volatile compared to CLLKF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check CLLKF's competition here
XVIPY vs EKDHF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, EKDHF has a market cap of 150.5M. Regarding current trading prices, XVIPY is priced at $6.54, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas EKDHF's P/E ratio is 34.96. In terms of profitability, XVIPY's ROE is +0.01%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, XVIPY is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check EKDHF's competition here
XVIPY vs PXMBF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, XVIPY is priced at $6.54, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, XVIPY's ROE is +0.01%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, XVIPY and PXMBF have similar daily volatility (0.00).Check PXMBF's competition here
XVIPY vs EAPIF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, XVIPY is priced at $6.54, while EAPIF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas EAPIF's P/E ratio is -0.60. In terms of profitability, XVIPY's ROE is +0.01%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, XVIPY is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check EAPIF's competition here
XVIPY vs AMEUF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, XVIPY is priced at $6.54, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, XVIPY's ROE is +0.01%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, XVIPY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check AMEUF's competition here
XVIPY vs SOMNF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, XVIPY is priced at $6.54, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, XVIPY and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
XVIPY vs JMDMF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, XVIPY is priced at $6.54, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, XVIPY's ROE is +0.01%, compared to JMDMF's ROE of N/A. Regarding short-term risk, XVIPY is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check JMDMF's competition here
XVIPY vs RSHUF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, XVIPY is priced at $6.54, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, XVIPY's ROE is +0.01%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, XVIPY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check RSHUF's competition here
XVIPY vs AVHHL Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, AVHHL has a market cap of 90.1M. Regarding current trading prices, XVIPY is priced at $6.54, while AVHHL trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas AVHHL's P/E ratio is -2.34. In terms of profitability, XVIPY's ROE is +0.01%, compared to AVHHL's ROE of +3.05%. Regarding short-term risk, XVIPY is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check AVHHL's competition here
XVIPY vs CKMTF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, XVIPY is priced at $6.54, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, XVIPY's ROE is +0.01%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, XVIPY and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
XVIPY vs SNZZF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, XVIPY is priced at $6.54, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas SNZZF's P/E ratio is -5.30. In terms of profitability, XVIPY's ROE is +0.01%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, XVIPY is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check SNZZF's competition here
XVIPY vs BLOZF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BLOZF has a market cap of 58.3M. Regarding current trading prices, XVIPY is priced at $6.54, while BLOZF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BLOZF's P/E ratio is -11.88. In terms of profitability, XVIPY's ROE is +0.01%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, XVIPY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check BLOZF's competition here
XVIPY vs TLTFF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, TLTFF has a market cap of 52.4M. Regarding current trading prices, XVIPY is priced at $6.54, while TLTFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas TLTFF's P/E ratio is -19.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, XVIPY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check TLTFF's competition here
XVIPY vs BRNHF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, XVIPY is priced at $6.54, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, XVIPY's ROE is +0.01%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, XVIPY and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here
XVIPY vs NVYTF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, XVIPY is priced at $6.54, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, XVIPY's ROE is +0.01%, compared to NVYTF's ROE of -1.22%. Regarding short-term risk, XVIPY and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
XVIPY vs RDGL Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RDGL has a market cap of 32.3M. Regarding current trading prices, XVIPY is priced at $6.54, while RDGL trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RDGL's P/E ratio is -6.69. In terms of profitability, XVIPY's ROE is +0.01%, compared to RDGL's ROE of -1.48%. Regarding short-term risk, XVIPY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check RDGL's competition here
XVIPY vs ACIXF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ACIXF has a market cap of 26.3M. Regarding current trading prices, XVIPY is priced at $6.54, while ACIXF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ACIXF's P/E ratio is -2.34. In terms of profitability, XVIPY's ROE is +0.01%, compared to ACIXF's ROE of -1.06%. Regarding short-term risk, XVIPY is less volatile compared to ACIXF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ACIXF's competition here
XVIPY vs MKEAF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, XVIPY is priced at $6.54, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, XVIPY's ROE is +0.01%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, XVIPY and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
XVIPY vs POSC Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, POSC has a market cap of 25.6M. Regarding current trading prices, XVIPY is priced at $6.54, while POSC trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas POSC's P/E ratio is -5.42. In terms of profitability, XVIPY's ROE is +0.01%, compared to POSC's ROE of -7.67%. Regarding short-term risk, XVIPY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check POSC's competition here
XVIPY vs TCLIF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, XVIPY is priced at $6.54, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, XVIPY's ROE is +0.01%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, XVIPY is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check TCLIF's competition here
XVIPY vs KBBTF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, XVIPY is priced at $6.54, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, XVIPY's ROE is +0.01%, compared to KBBTF's ROE of N/A. Regarding short-term risk, XVIPY and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
XVIPY vs PYNKF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, PYNKF has a market cap of 23.6M. Regarding current trading prices, XVIPY is priced at $6.54, while PYNKF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas PYNKF's P/E ratio is 3.75. In terms of profitability, XVIPY's ROE is +0.01%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, XVIPY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check PYNKF's competition here
XVIPY vs EMITF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, XVIPY is priced at $6.54, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas EMITF's P/E ratio is -7.62. In terms of profitability, XVIPY's ROE is +0.01%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, XVIPY and EMITF have similar daily volatility (0.00).Check EMITF's competition here
XVIPY vs VPTDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, VPTDF has a market cap of 20.9M. Regarding current trading prices, XVIPY is priced at $6.54, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas VPTDF's P/E ratio is -11.12. In terms of profitability, XVIPY's ROE is +0.01%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, XVIPY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check VPTDF's competition here
XVIPY vs DIZTF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, XVIPY is priced at $6.54, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, XVIPY's ROE is +0.01%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, XVIPY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check DIZTF's competition here
XVIPY vs MDXHF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, XVIPY is priced at $6.54, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, XVIPY's ROE is +0.01%, compared to MDXHF's ROE of +0.66%. Regarding short-term risk, XVIPY and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here
XVIPY vs IPDQF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, IPDQF has a market cap of 14.3M. Regarding current trading prices, XVIPY is priced at $6.54, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas IPDQF's P/E ratio is -0.70. In terms of profitability, XVIPY's ROE is +0.01%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, XVIPY is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check IPDQF's competition here
XVIPY vs ASAPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ASAPF has a market cap of 14.1M. Regarding current trading prices, XVIPY is priced at $6.54, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ASAPF's P/E ratio is -18.01. In terms of profitability, XVIPY's ROE is +0.01%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, XVIPY and ASAPF have similar daily volatility (0.00).Check ASAPF's competition here
XVIPY vs GTHP Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, GTHP has a market cap of 14M. Regarding current trading prices, XVIPY is priced at $6.54, while GTHP trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas GTHP's P/E ratio is -4.57. In terms of profitability, XVIPY's ROE is +0.01%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, XVIPY and GTHP have similar daily volatility (0.00).Check GTHP's competition here
XVIPY vs TMDIF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, XVIPY is priced at $6.54, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, XVIPY's ROE is +0.01%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, XVIPY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check TMDIF's competition here
XVIPY vs ATBPF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, XVIPY is priced at $6.54, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, XVIPY's ROE is +0.01%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, XVIPY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ATBPF's competition here
XVIPY vs LXXGF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, XVIPY is priced at $6.54, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, XVIPY's ROE is +0.01%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, XVIPY and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
XVIPY vs ALRTF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ALRTF has a market cap of 10.6M. Regarding current trading prices, XVIPY is priced at $6.54, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ALRTF's P/E ratio is -0.41. In terms of profitability, XVIPY's ROE is +0.01%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, XVIPY is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ALRTF's competition here
XVIPY vs PLLWF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, XVIPY is priced at $6.54, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, XVIPY's ROE is +0.01%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, XVIPY is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check PLLWF's competition here
XVIPY vs BIEL Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, BIEL has a market cap of 7.2M. Regarding current trading prices, XVIPY is priced at $6.54, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas BIEL's P/E ratio is N/A. In terms of profitability, XVIPY's ROE is +0.01%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, XVIPY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check BIEL's competition here
XVIPY vs USAQ Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, USAQ has a market cap of 6.4M. Regarding current trading prices, XVIPY is priced at $6.54, while USAQ trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas USAQ's P/E ratio is 26.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to USAQ's ROE of +0.92%. Regarding short-term risk, XVIPY and USAQ have similar daily volatility (0.00).Check USAQ's competition here
XVIPY vs PMEDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, PMEDF has a market cap of 6.2M. Regarding current trading prices, XVIPY is priced at $6.54, while PMEDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas PMEDF's P/E ratio is -3.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, XVIPY is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check PMEDF's competition here
XVIPY vs QLIS Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, XVIPY is priced at $6.54, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas QLIS's P/E ratio is 2.22. In terms of profitability, XVIPY's ROE is +0.01%, compared to QLIS's ROE of -0.15%. Regarding short-term risk, XVIPY and QLIS have similar daily volatility (0.00).Check QLIS's competition here
XVIPY vs RHNMF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, XVIPY is priced at $6.54, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, XVIPY's ROE is +0.01%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, XVIPY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check RHNMF's competition here
XVIPY vs ADMT Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ADMT has a market cap of 5.4M. Regarding current trading prices, XVIPY is priced at $6.54, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ADMT's P/E ratio is -8.00. In terms of profitability, XVIPY's ROE is +0.01%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, XVIPY is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ADMT's competition here
XVIPY vs ELXMF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, ELXMF has a market cap of 4.1M. Regarding current trading prices, XVIPY is priced at $6.54, while ELXMF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas ELXMF's P/E ratio is -0.72. In terms of profitability, XVIPY's ROE is +0.01%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, XVIPY is less volatile compared to ELXMF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check ELXMF's competition here
XVIPY vs RMSL Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, RMSL has a market cap of 4.1M. Regarding current trading prices, XVIPY is priced at $6.54, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas RMSL's P/E ratio is 0.24. In terms of profitability, XVIPY's ROE is +0.01%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, XVIPY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check RMSL's competition here
XVIPY vs NGMDF Comparison May 2026
XVIPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XVIPY stands at 206M. In comparison, NGMDF has a market cap of 3.7M. Regarding current trading prices, XVIPY is priced at $6.54, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XVIPY currently has a P/E ratio of N/A, whereas NGMDF's P/E ratio is -0.55. In terms of profitability, XVIPY's ROE is +0.01%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, XVIPY is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for XVIPY.Check NGMDF's competition here